Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05919342 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"

Study acronym: SYMPHONY-HF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 4, 2023 (before its estimated June 21, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description expanded, about 20 words
    • Collaborators: 11 to 12
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
Trial Details
NCT Number NCT05919342
Lead Sponsor NHS Greater Glasgow and Clyde
Collaborators: University of Glasgow, National Heart Centre Singapore, Karolinska University Hospital, Uppsala University, Montreal Heart Institute, Rigshospitalet, Denmark, University of British Columbia, The Cleveland Clinic, Université de Montréal, AstraZeneca, Roche Pharma AG, Us2.ai
Conditions
(from sponsor)		 Heart Failure, Cardiovascular Diseases
Related terms Cardiovascular Diseases, Heart Failure
Enrollment 3,904 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov